top of page

Crosshair Therapeutics

Founded Year:

2021

Stage:

Seed

Website:

Crosshair Therapeutics harnesses machine learning and a novel high-precision protein targeting technology to design a new class of DNA-based therapeutics computationally. Crosshair's unique platform enables unrestricted access to the most difficult disease targets.

Subscribe to our news letter. Don't miss out!

Thanks for subscribing!

©2022 H7 BioCapital

All rights reserved.

bottom of page